No Data
The "Congressional stock gods" have new actions: In the past six months, they have invested 2.9 million dollars in pharmaceutical companies.
① Due to Trump's tariffs and Health Secretary Kennedy's reforms, stock prices in the American pharmaceutical Industry have been falling consistently; ② Although the stock prices of pharmaceutical companies have underperformed the market, U.S. Congress members are constantly Buying pharmaceutical company Stocks; ③ Financial disclosures show that during the first six months of the Trump administration, U.S. Representatives and Senators purchased up to $2.9 million in pharmaceutical company Stocks.
Institutions: Chinese innovative drugs are booming, but how far are they from the international leading level?
Tianfeng believes that the gap between China and the world in terms of the time for the first innovative drug to be listed for the same target has reduced from over 10 years to within 1-5 years; in terms of clinical quantities, Chinese innovative drugs now account for over 30% globally, and popular targets exceed 60%; regarding BD transactions with upfront payments of over 50 million dollars, the share of Chinese molecular projects has surpassed 25%.
Johnson & Johnson's Imaavy Shows 'Significant Improvement' Over Other Treatments for Autoimmune Disorder
Express News | Johnson & Johnson - Lens Available in U.S. and Canada, More Launches Expected Later This Summer
Express News | Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - Acuvue Oasys Max 1-Day Multifocal for Astigmatism
Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM
